+49 (0) 162 2343 600 | E-Mail: info@healthcareshapers.com
  • LANGUAGES
    • Deutsch Deutsch
    • English English
    • Français Français

Healthcare Shapers

  • About us
  • Clients
  • Contact
  • Services
  • Collaborators
  • Blog
  • News
 5. February 2023

3 Essential Strategies To Healthcare Commercial Success

3 Essential Strategies To Healthcare Commercial Success

by Healthcare Shapers Perspectives / Wednesday, 14 July 2021 / Published in Perspectives, Uncategorized

Healthcare Shapers Perspectives Guest:
Erkan Hassan, PharmD, FCCM
Chief Clinical Officer, Sepsis Program Optimization

Innovative technology alone does not ensure success.  Clinicians and technology groups are accustomed to working in divergent methods and cultures.  Combining the 2 approaches is critical for success.

Healthcare poses unique characteristics for innovators vs other industries. Innovators need to determine the optimal solution during development; evaluating their solution through the clinical outcome lens and prepare for after the sale solution support. Healthcare innovators have to blend clinical needs to meet business success.

Listen or watch as Erkan Hassan describes how to address clinical validation, integration into clinician workflows and selective metrics to demonstrate success.

Join us on LinkedIn for a discussion of this episode.


Healthcare Shapers Perspective Podcast

Healthcare Shapers Perspectives Podcast: Accelerating Digital Health Innovation Adoption

Healthcare Shapers Perspectives Video

Erkan Hassan couples 19 years of bedside clinical experience with 20 years of designing and implementing innovative technologies within integrated health delivery systems to deliver quantified patient centered clinical and financial outcomes.

Erkan helps healthcare innovators maximize clinical acceptance by leveraging the synergy of interdisciplinary clinical transformation and technology to solve health systems challenges to improve outcomes.

  • Tweet

What you can read next

Personalisierte Medizin: Fortschritt – nur für wenige, oder doch für alle?
Personalised medicine: progress – only for a few, or for all?
Faster time to market, less funds: How to survive as a BioTech Startup?
Faster time to market, less funds: How to survive as a BioTech Startup?
Accelerating the Adoption of Digital Health Innovation

Suche

Letzte Beiträge

  • Strategie trifft Umsetzung

    Driving the Strategy Execution

    In our complex and busy world, a lot of focus i...
  • Faster time to market, less funds: How to survive as a BioTech Startup?

    Faster time to market, less funds: How to survive as a BioTech Startup?

    The climate of overall uncertainty in markets i...
  • Building vs. Breaking Mental Health with Digital Technology

    Healthcare Shapers Perspectives Guest: Craig A....
  • From Crisis to Clarity

    Healthcare Shapers Perspectives Guest: Kathy Le...
  • Personalisierte Medizin: Fortschritt – nur für wenige, oder doch für alle?

    Personalised medicine: progress – only for a few, or for all?

    Personalised medicine is the topic at medical c...

Archiv

  • January 2023
  • August 2022
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2020
  • March 2020
  • December 2019
  • September 2019
  • November 2018
  • March 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • April 2017

Kategorien

  • digitalization
  • e-health
  • Innovative Care
  • leadership
  • Market Access
  • Mobile
  • patient-centricity
  • Perspectives
  • Strategy
  • Technology
  • Telehealth
  • Uncategorized
  • Virtual Reality

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Empfohlen

  • Strategie trifft Umsetzung

    Driving the Strategy Execution

    0 comments
  • Faster time to market, less funds: How to survive as a BioTech Startup?

    Faster time to market, less funds: How to survive as a BioTech Startup?

    0 comments
  • Building vs. Breaking Mental Health with Digital Technology

    0 comments
  • From Crisis to Clarity

    0 comments
  • Personalisierte Medizin: Fortschritt – nur für wenige, oder doch für alle?

    Personalised medicine: progress – only for a few, or for all?

    0 comments

NAVIGATION

  • About us
  • Clients
  • Contact
  • Services
  • Collaborators
  • Blog
  • News

NEWSLETTER

Enter your e-mail address and we will gladly keep you informed about current topics and upcoming events.

RSS-Feed abonnierenRSS-Feed abonnieren

HEALTHCARE SHAPERS

Günther Illert
(Founder of the network)
Rheingauer Straße 49c
D-65343 Eltville
Germany

M +49 (0) 162 2343 600

E-Mail:info@healthcareshapers.com

  • About us
  • Contact
  • Site Notice
  • Privacy Policy
  • GET SOCIAL

Healthcare Shapers© 2018 All rights reserved.

TOP
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Read More
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT